Angiex is a biotechnology company that researches and develops an antibody-drug conjugate therapy for cancer against a vascular target, TM4SF1.
Business Model:
Revenue: $0
Employees: 1-10
Address: 393 Broadway Apt 15
City: Cambridge
State: MA
Zip: 02139
Country: US
Angiex is a biotechnology company that researches and develops an antibody-drug conjugate therapy for cancer against a vascular target, TM4SF1.
Contact Phone:
+16175761753
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2017 | Series A | 1 | $3M |
Thiel Capital Thiel Capital |
11/2016 | Non Equity Assistance | 1 | - |
MassChallenge MassChallenge |
7/2017 | Venture Round | $2.9M | 10/2020 | Venture Round | 1 | $2M |
Presight Capital Presight Capital |
4/2021 | Series B | 2 | $25M |
Presight Capital Thiel Capital Presight Capital Thiel Capital |
11/2016 | Non Equity Assistance | 1 | - |
MassChallenge MassChallenge |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|